Alkermes drug shows sustained narcolepsy benefits at nine months
Go back to Alkermes drug shows sustained narcolepsy benefits at nine months| ALKERMES (NASDAQ: ALKS) | Delayed: 45.38 -0.11 (0.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.49 | 52 Week High | $80.71 | |||
| Open | $45.24 | 52 Week Low | $27.14 | |||
| Day High | $45.61 | P/E | 349.08 | |||
| Day Low | $44.72 | EPS | $0.13 | |||
| Volume | 457,754 | |||||
